Norwood updates IPO

Norwood Immunology (Melbourne, Australia) amended its IPO and now hopes to raise about AUS$15 million ($10.3 million) through the sale of 15 million shares at AUS$1, which would give it a post-money valuation of AUS$122 million ($84.1 million). The company, which plans to list its shares on London's AIM market on June 30, proposed in April to raise AUS$37 million. ...